UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unraveling the mysteries of serum albumin-more than just a serum protein

Frontiers in physiology, 2014, Vol.5, p.299-299

2014

Volltextzugriff (PDF)

Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2

The Journal of biological chemistry, 2016-08, Vol.291 (33), p.17303-17318

2016

Volltextzugriff (PDF)

CD63 is regulated by iron via the IRE-IRP system and is important for ferritin secretion by extracellular vesicles

Blood, 2021-10, Vol.138 (16), p.1490-1503

2021

Volltextzugriff (PDF)

The active role of vitamin C in mammalian iron metabolism: Much more than just enhanced iron absorption

Free radical biology & medicine, 2014-10, Vol.75, p.69-83

2014

Volltextzugriff (PDF)

Molecular pharmacology of ABCG2 and its role in chemoresistance

Molecular pharmacology, 2013-11, Vol.84 (5), p.655-669

2013

Volltextzugriff (PDF)

The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity

International journal of molecular sciences, 2020-09, Vol.21 (18), p.6805

2020

Volltextzugriff (PDF)

The evolution of iron chelators for the treatment of iron overload disease and cancer

Pharmacological reviews, 2005-12, Vol.57 (4), p.547-583

2005

Volltextzugriff (PDF)

Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1

The Journal of biological chemistry, 2011-04, Vol.286 (17), p.15413-15427

2011

Volltextzugriff (PDF)

The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells

Biochimica et biophysica acta, 2016-12, Vol.1863 (12), p.2916-2933

2016

Volltextzugriff (PDF)

Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer

Molecular pharmacology, 2011-10, Vol.80 (4), p.598-609

2011

Volltextzugriff (PDF)

The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer

The Journal of biological chemistry, 2021-12, Vol.297 (6), p.101414-101414, Article 101414

2021

Volltextzugriff (PDF)

A Class of Iron Chelators with a Wide Spectrum of Potent Antitumor Activity That Overcomes Resistance to Chemotherapeutics

Proceedings of the National Academy of Sciences - PNAS, 2006-10, Vol.103 (40), p.14901-14906

2006

Volltextzugriff (PDF)

Non-thermal plasma induces a stress response in mesothelioma cells resulting in increased endocytosis, lysosome biogenesis and autophagy

Free radical biology & medicine, 2017-07, Vol.108, p.904-917

2017

Volltextzugriff (PDF)

Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity

Free radical biology & medicine, 2019-03, Vol.133, p.276-294

2019

Volltextzugriff (PDF)

Gene of the month: Interleukin 6 (IL-6)

Journal of clinical pathology, 2014-11, Vol.67 (11), p.932-937

2014

Volltextzugriff (PDF)

The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways

Antioxidants & redox signaling, 2013-03, Vol.18 (8), p.874-887

2013

Volltextzugriff (PDF)

Changes in ferrous iron and glutathione promote ferroptosis and frailty in aging Caenorhabditis elegans

eLife, 2020-07, Vol.9

2020

Volltextzugriff (PDF)

Targeting cancer by binding iron: Dissecting cellular signaling pathways

Oncotarget, 2015-08, Vol.6 (22), p.18748-18779

2015

Volltextzugriff (PDF)

Structure–Activity Relationships of Di-2-pyridylketone, 2‑Benzoylpyridine, and 2‑Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance

Journal of medicinal chemistry, 2016-09, Vol.59 (18), p.8601-8620

2016

Volltextzugriff (PDF)

The good Samaritan glutathione-S-transferase P1: An evolving relationship in nitric oxide metabolism mediated by the direct interactions between multiple effector molecules

Redox biology, 2023-02, Vol.59, p.102568, Article 102568

2023

Volltextzugriff (PDF)

The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the “Triad of Death” in cancer by Di-2-pyridylketone thiosemicarbazones

Pharmacological research, 2015-10, Vol.100, p.255-260

2015

Volltextzugriff (PDF)

Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter

The Journal of biological chemistry, 2016-02, Vol.291 (8), p.3796-3820

2016

Volltextzugriff (PDF)

Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships

PloS one, 2014-10, Vol.9 (10), p.e110291-e110291

2014

Volltextzugriff (PDF)

Breaking the cycle: Targeting of NDRG1 to inhibit bi‐directional oncogenic cross‐talk between pancreatic cancer and stroma

The FASEB journal, 2021-02, Vol.35 (2), p.e21347-n/a

2021

Volltextzugriff (PDF)

Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (24), p.10775-10782

2010

Volltextzugriff (PDF)

1 – 25 von 518

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(460)
Mit Volltextzugriff
(457)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(328)
Life Sciences & Biomedicine
(300)
Humans
(265)
Animals
(134)
Biochemistry & Molecular Biology
(127)
Iron - Metabolism
(122)
Iron
(90)
Cell Line, Tumor
(87)
Pharmacology & Pharmacy
(84)
Iron Chelating Agents - Pharmacology
(77)
Antineoplastic Agents - Pharmacology
(76)
Thiosemicarbazones - Pharmacology
(72)
Biological And Medical Sciences
(63)
Cell Biology
(55)
Physical Sciences
(54)
Chemistry
(52)
Iron Chelating Agents - Chemistry
(49)
Medical Sciences
(48)
Cell Proliferation - Drug Effects
(43)
Chemistry, Medicinal
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Unraveling the mysteries of serum albumin-more than just a serum protein

Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2

CD63 is regulated by iron via the IRE-IRP system and is important for ferritin secretion by extracellular vesicles

The active role of vitamin C in mammalian iron metabolism: Much more than just enhanced iron absorption

Molecular pharmacology of ABCG2 and its role in chemoresistance

The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity

The evolution of iron chelators for the treatment of iron overload disease and cancer

Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1

The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells

Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer

The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer

A Class of Iron Chelators with a Wide Spectrum of Potent Antitumor Activity That Overcomes Resistance to Chemotherapeutics

Non-thermal plasma induces a stress response in mesothelioma cells resulting in increased endocytosis, lysosome biogenesis and autophagy

Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity

Gene of the month: Interleukin 6 (IL-6)

The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways

Changes in ferrous iron and glutathione promote ferroptosis and frailty in aging Caenorhabditis elegans

Targeting cancer by binding iron: Dissecting cellular signaling pathways

Structure–Activity Relationships of Di-2-pyridylketone, 2‑Benzoylpyridine, and 2‑Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance

The good Samaritan glutathione-S-transferase P1: An evolving relationship in nitric oxide metabolism mediated by the direct interactions between multiple effector molecules

The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the “Triad of Death” in cancer by Di-2-pyridylketone thiosemicarbazones

Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter

Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships

Breaking the cycle: Targeting of NDRG1 to inhibit bi‐directional oncogenic cross‐talk between pancreatic cancer and stroma

Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol

Suchergebnisse filtern